Strain-specific Plasmodium falciparum multifunctional CD4+ T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate
Shawna F. Graves(University of Maryland, Baltimore), Kirsten E. Lyke(University of Maryland, Baltimore), David E. Lanar(Walter Reed Army Institute of Research), Marcelo B. Sztein(University of Maryland, Baltimore), Bourèma Kouriba(Centre Pour le Développement des Vaccins-Mali), Matthew B. Laurens(University of Maryland, Baltimore), Christopher V. Plowe(University of Maryland, Baltimore), Issa Diarra(University of Bamako), Drissa Coulibaly(University of Maryland, Baltimore), Johan Vekemans(MRC Unit the Gambia), Amadou Niangaly(University of Bamako), Mahamadou A. Théra(University of Bamako), Andrea A. Berry(University of Maryland, Baltimore), Yamoussa Keita(Malaria Research and Training Center), Modibo Daou(University of Bamako), W. Ripley Ballou(Walter Reed Army Institute of Research), Ogobara K. Doumbo(University of Bamako), D. Gray Heppner(Dallas VA Medical Center), Lorraine Soisson(United States Agency for International Development), Carter L. Diggs(United States Agency for International Development), Sheetij Dutta(Walter Reed Army Institute of Research)
Cited by 12
Related Papers
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k
Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
|Science|2013|783
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
|The Lancet|2001|528
Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses
|Clinical Infectious Diseases|2017|453